Abstract

The present study was designed to investigate the function of death-associated protein kinase 1 (DAPK1) in infantile pneumonia and explore the potential mechanism of the actions. Male C57BL/6 mice were injected with 2 mg/kg of LPS for the mice model of infantile pneumonia. A549 cells were treated with 100 ng/ml of LPS for vitro model of infantile pneumonia. Dapk1 mRNA and protein expressions in 6, 12 or 24 h after induction model of mice. Dapk1 gene increased inflammation in vitro model through activation of p38MAPK-mediated NF-κB expression. The inhibition of p38MAPK or NF-κB reduced the pro-inflammation effects of DAPK1 in infantile pneumonia. Our study demonstrates that Dapk1 promoted inflammation of infantile pneumonia by p38MAPK/NF-κB signaling pathway, may be achieved inflammation by activation of p38MAPK/NF-κB signaling pathway.

Highlights

  • Mycoplasmal pneumonia is a respiratory infection caused by mycoplasma pneumoniae, which is clinically manifested by fever, cough, sputum expectoration, anorexia, headache, sore throat, substernal pain and chills [1]

  • Our study demonstrates that Dapk1 promoted inflammation of infantile pneumonia by p38MAPK/NF-κB signaling pathway, may be achieved inflammation by activation of p38MAPK/NF-κB signaling pathway

  • We used vitro model to analyze the effects of Dapk1 gene on infantile pneumonia

Read more

Summary

Introduction

Mycoplasmal pneumonia is a respiratory infection caused by mycoplasma pneumoniae, which is clinically manifested by fever, cough, sputum expectoration, anorexia, headache, sore throat, substernal pain and chills [1]. The more atypical clinical symptoms are generally detected in younger children, often accompanied with multi-system and multi-organ functional damage [2]. Infantile mycoplasmal pneumonia is one of the main causes of respiratory infection in children [2]. The etiology of infantile pneumonia is not completely clear, which might be associated with the humoral and cellular immunity of the children [3]. Anti-infection and symptomatic treatment are the main therapeutic approaches. The present study was designed to investigate the function of Death associated protein kinase 1 (DAPK1) in infantile pneumonia and explore the potential mechanism of the actions

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.